Clinical Trial Update: Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer [NA]

View source ↗

Summary

A clinical trial update evaluating the accuracy of the PET tracer 18F-rhPSMA-7.3 in combination with MRI to predict lymph node metastasis in localized high-risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer
• Oligometastatic Prostate Cancer
• Prostate Cancer

Drugs mentioned

• 18F-rhPSMA-7.3 (rhPSMA-7.3 radiotracer)

Snippet

Sponsor: Mayo Clinic | Conditions: Localized Prostate Carcinoma, Oligometastatic Prostate Carcinoma | NA | Status: RECRUITING